Swiss pharmaceutical giant Novartis reported a 2.8 percent drop in sales in the first quarter of 2016, when its revenue dropped to $11.6 billion from $11.9 billion in the same period last year. Analysts had forecast revenue for the quarter at $11.8 billion.
